NEW YORK (GenomeWeb News) – AutoGenomics, which has filed for an initial public offering, said revenues through the first nine months of the year increased to $14.5 million from $5.2 million a year ago.

For the nine months ended Sept. 30, revenue from consumables sales totaled $13. 2 million, it said in its Form S-1/A filed with the US Securities and Exchange Commission on Thursday. The company added that it expects the majority of revenues to continue to come from genetic test consumable sales "for the foreseeable future."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.